{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:30:50Z","timestamp":1793395850421,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["U24CA076518"],"award-info":[{"award-number":["U24CA076518"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75R60222C00011"],"award-info":[{"award-number":["75R60222C00011"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA076518"],"award-info":[{"award-number":["U24CA076518"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["N00014-25-1-2146"],"award-info":[{"award-number":["N00014-25-1-2146"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtct.2026.04.038","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:32:02Z","timestamp":1777606322000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors Associated with Receipt of Allogeneic Hematopoietic Cell Transplant and NMDP Donor Search in Older Adults with Acute Myeloid Leukemia"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-5720","authenticated-orcid":false,"given":"Jaime M.","family":"Preussler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2660-2344","authenticated-orcid":false,"given":"Christa L.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4628-0015","authenticated-orcid":false,"given":"Mari\u00e9tou H.","family":"Ouayogod\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0625-2861","authenticated-orcid":false,"given":"Marguerite","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.04.038_bib0001","unstructured":"SEER. Acute Myeloid Leukemia - Cancer Stat Facts. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html. Accessed April 15, 2026."},{"issue":"12","key":"10.1016\/j.jtct.2026.04.038_bib0002","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/cncr.33458","article-title":"de novo acute myeloid leukemia: a population- based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) Database, 1980\u20132017","volume":"127","author":"Sasaki","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.038_bib0003","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cncr.33873","article-title":"Frontline treatment patterns and outcomes among older adults with acute myeloid leukemia: A population-based analysis in the modern era","volume":"128","author":"Kennedy","year":"2022","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jtct.2026.04.038_bib0004","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00277-015-2351-x","article-title":"Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States","volume":"94","author":"Medeiros","year":"2015","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.038_bib0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","article-title":"AML treatment: conventional chemotherapy and emerging novel agents","volume":"45","author":"Forsberg","year":"2024","journal-title":"Trends Pharmacol Sci"},{"issue":"23","key":"10.1016\/j.jtct.2026.04.038_bib0006","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1002\/cncr.32439","article-title":"Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis","volume":"125","author":"Zeidan","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2026.04.038_bib0007","unstructured":"NMDP. Acute myeloid leukemia (AML). Available at: https:\/\/network.nmdp.org\/services-support\/hematology-oncology\/consultation-guidelines-outcomes\/disease-specific-indications\/acute-myeloid-leukemia-aml. Accessed April 15, 2026."},{"key":"10.1016\/j.jtct.2026.04.038_bib0008","article-title":"Enhancing administrative claims data: feasibility, validation and application of linking Medicare claims data and National Marrow Donor Program search data","volume":"6","author":"Preussler","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.jtct.2026.04.038_bib0009","article-title":"Barriers to access to hematopoietic cell transplantation among patients with acute myeloid leukemia in Virginia","author":"Mock","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.038_bib0010","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jtct.2022.09.015","article-title":"Trends in allogeneic hematopoietic cell transplantation utilization and estimated unmet need among Medicare beneficiaries with acute myelogenous leukemia","volume":"28","author":"Mau","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"13","key":"10.1016\/j.jtct.2026.04.038_bib0011","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2217\/fon-2017-0599","article-title":"Factors associated with receipt of hematopoietic cell transplantation for acute lymphoblastic leukemia","volume":"14","author":"Manikkam Umakanthan","year":"2018","journal-title":"Future Oncol Lond Engl"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.038_bib0012","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/hematology.2021000259","article-title":"Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics","volume":"2021","author":"Hong","year":"2021","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.038_bib0013","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/1475-6773.12208","article-title":"Factors affecting receipt of expensive cancer treatments and mortality: evidence from stem cell transplantation for leukemia and lymphoma","volume":"50","author":"Mitchell","year":"2015","journal-title":"Health Serv Res"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.038_bib0014","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/10428194.2020.1832662","article-title":"Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists","volume":"62","author":"Loh","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"23","key":"10.1016\/j.jtct.2026.04.038_bib0015","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood-2010-07-259358","article-title":"Who is fit for allogeneic transplantation?","volume":"116","author":"Deeg","year":"2010","journal-title":"Blood"},{"issue":"16 Suppl","key":"10.1016\/j.jtct.2026.04.038_bib0016","first-page":"S347","article-title":"Unmet clinical needs and economic burden of disease in the treatment landscape of acute myeloid leukemia","volume":"24","author":"Wiese","year":"2018","journal-title":"Am J Manag Care"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.038_bib0017","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11912-020-00987-8","article-title":"Access to therapy for acute myeloid leukemia in the developing world: barriers and solutions","volume":"22","author":"Meillon-Garcia","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.038_bib0018","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/COC.0b013e3181dea934","article-title":"Effects of poverty and race on outcomes in acute myeloid leukemia","volume":"34","author":"Byrne","year":"2011","journal-title":"Am J Clin Oncol"},{"issue":"20","key":"10.1016\/j.jtct.2026.04.038_bib0019","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1002\/cncr.26095","article-title":"Acute myeloid leukemia: How the uninsured fare","volume":"117","author":"Bradley","year":"2011","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jtct.2026.04.038_bib0020","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1182\/blood-2003-09-3118","article-title":"Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia","volume":"103","author":"Sekeres","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.038_bib0021","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1200\/JCO.2008.18.2006","article-title":"Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in Sweden","volume":"27","author":"Kristinsson","year":"2009","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.jtct.2026.04.038_bib0022","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1200\/JCO.2017.73.6728","article-title":"Effects of education and income on treatment and outcome in patients with acute myeloid leukemia in a tax-supported health care system: a national population-based cohort study","volume":"35","author":"\u00d8stg\u00e5rd","year":"2017","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jtct.2026.04.038_bib0023","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41409-018-0164-y","article-title":"Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.038_bib0024","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3324\/haematol.2018.192468","article-title":"Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey","volume":"103","author":"Bories","year":"2018","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.038_bib0025","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.6004\/jnccn.2019.7327","article-title":"Addressing knowledge gaps in acute myeloid leukemia to improve referral for hematopoietic cell transplantation consultation","volume":"17","author":"Meyer","year":"2019","journal-title":"J Natl Compr Cancer Netw"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.038_bib0026","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1016\/j.jtct.2025.01.528","article-title":"Trends in hematology-oncology physician perceptions and referral behaviors for allogeneic hematopoietic cell transplant","volume":"31","author":"Pidala","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2026.04.038_bib0027","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/1475-6773.12605","article-title":"Organizational factors affect safety-net hospitals\u2019 breast cancer treatment rates","volume":"52","author":"Bickell","year":"2017","journal-title":"Health Serv Res"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.038_bib0028","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10549-012-1955-2","article-title":"Structural\/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients","volume":"133","author":"Wheeler","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.038_bib0029","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1200\/OP.21.00351","article-title":"Physician influence on variation in receipt of aggressive end-of-life care among women dying of ovarian cancer","volume":"18","author":"Mullins","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jtct.2026.04.038_bib0030","unstructured":"Provider of Services Current Files | CMS. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Downloadable-Public-Use-Files\/Provider-of-Services Accessed April 22, 2023."},{"key":"10.1016\/j.jtct.2026.04.038_bib0031","unstructured":"Hospital General Information | Provider Data Catalog. Available at: https:\/\/data.cms.gov\/provider-data\/dataset\/xubh-q36u. Accessed April 22, 2023."},{"key":"10.1016\/j.jtct.2026.04.038_bib0032","unstructured":"NPPES NPI Registry. Available at: https:\/\/npiregistry.cms.hhs.gov\/search. Accessed April 22, 2023."},{"key":"10.1016\/j.jtct.2026.04.038_bib0033","unstructured":"National Downloadable File | Provider Data Catalog. Accessed Available at: https:\/\/data.cms.gov\/provider-data\/dataset\/mj5m-pzi6. April 22, 2023."},{"issue":"1","key":"10.1016\/j.jtct.2026.04.038_bib0034","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.jtct.2026.04.038_bib0035","unstructured":"Social Deprivation Index (SDI). Available at: https:\/\/www.graham-center.org\/content\/brand\/rgc\/maps-data-tools\/social-deprivation-index.html. Accessed April 15, 2026."},{"issue":"14","key":"10.1016\/j.jtct.2026.04.038_bib0037","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood.2021012830","article-title":"Structural racism is a mediator of disparities in acute myeloid leukemia outcomes","volume":"139","author":"Abraham","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.04.038_bib0038","unstructured":"Hospitals - Overall hospital quality star rating | Provider Data Catalog. Available at: https:\/\/data.cms.gov\/provider-data\/topics\/hospitals\/overall-hospital-quality-star-rating\/. Accessed November 24, 2025."},{"issue":"11","key":"10.1016\/j.jtct.2026.04.038_bib0039","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1118\/1.2794176","article-title":"Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test","volume":"34","author":"Glatting","year":"2007","journal-title":"Med Phys"},{"issue":"9","key":"10.1016\/j.jtct.2026.04.038_bib0040","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.038_bib0041","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.bbmt.2020.09.013","article-title":"Barriers to hematopoietic cell transplantation for adults in the United States: a systematic review with a focus on age","volume":"26","author":"Flannelly","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.038_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174760","article-title":"Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients","volume":"12","author":"Jabo","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.038_bib0043","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bmt.2012.95","article-title":"Practice variation in physician referral for allogeneic hematopoietic cell transplantation","volume":"48","author":"Pidala","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.04.038_bib0044","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41409-022-01650-5","article-title":"Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis","volume":"57","author":"Maakaron","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.04.038_bib0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jtct.2025.05.014","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy - a report from the CIBMTR","volume":"31","author":"Spellman","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"19","key":"10.1016\/j.jtct.2026.04.038_bib0046","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2012.46.6193","article-title":"Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors","volume":"31","author":"Hahn","year":"2013","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.jtct.2026.04.038_bib0047","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/bloodadvances.2025015964","article-title":"Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703","volume":"9","author":"Abedin","year":"2025","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jtct.2026.04.038_bib0048","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.038_bib0049","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40258-013-0032-2","article-title":"Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs","volume":"11","author":"Meyers","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.038_bib0050","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood-2016-01-635060","article-title":"How I treat acute myeloid leukemia presenting with preexisting comorbidities","volume":"128","author":"Ofran","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.038_bib0051","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.038_bib0052","doi-asserted-by":"crossref","first-page":"184.e1","DOI":"10.1016\/j.bbmt.2020.10.004","article-title":"Likelihood of proceeding to allogeneic hematopoietic cell transplantation in the United States after search activation in the National Registry: impact of patient age, disease, and search prognosis","volume":"27","author":"Dehn","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.038_bib0053","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbmt.2015.09.012","article-title":"On modeling human leukocyte antigen-identical sibling match probability for allogeneic hematopoietic cell transplantation: estimating the need for an unrelated donor source","volume":"33","author":"Besse","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2026.04.038_bib0054","doi-asserted-by":"crossref","first-page":"686.e1","DOI":"10.1016\/j.jtct.2023.08.014","article-title":"Existence of HLA-mismatched unrelated donors closes the gap in donor availability regardless of recipient ancestry","volume":"29","author":"Chowdhury","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"18","key":"10.1016\/j.jtct.2026.04.038_bib0055","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.20.03502","article-title":"National Marrow Donor Program-sponsored multicenter, Phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide","volume":"39","author":"Shaw","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.038_bib0056","doi-asserted-by":"crossref","first-page":"208.e1","DOI":"10.1016\/j.jtct.2022.12.017","article-title":"Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplantation cyclophosphamide: follow-up from a National Marrow Donor Program-sponsored prospective clinical trial","volume":"29","author":"Shaw","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"28","key":"10.1016\/j.jtct.2026.04.038_bib0057","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.24.00184","article-title":"Post-transplant cyclophosphamide\u2013based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated donors","volume":"42","author":"Shaffer","year":"2024","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jtct.2026.04.038_bib0058","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bbmt.2015.03.020","article-title":"National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.038_bib0059","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/bmt.2015.246","article-title":"Geographic access to hematopoietic cell transplantation services in the United States","volume":"51","author":"Delamater","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"16_suppl","key":"10.1016\/j.jtct.2026.04.038_bib0060","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.1528","article-title":"Identifying states for targeted alloHCT access initiatives using social vulnerability, physician density, and unmet need","volume":"42","author":"Watters","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.038_bib0061","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/s12913-019-4815-5","article-title":"Access to specialty healthcare in urban versus rural US populations: a systematic literature review","volume":"19","author":"Cyr","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jtct.2026.04.038_bib0062","article-title":"Health Coverage and Care in the South in 2014 and Beyond","author":"Stephens","year":"2014","journal-title":"KFF"},{"key":"10.1016\/j.jtct.2026.04.038_bib0063","unstructured":"NMDP. HLA Today. Available at: https:\/\/network.nmdp.org\/services-support\/transplant-centers\/search-and-testing-services\/hla-today. Accessed April 15, 2026."},{"issue":"1","key":"10.1016\/j.jtct.2026.04.038_bib0064","first-page":"3061","article-title":"social determinants of health, and disease prevention and control","volume":"6","author":"Coughlin","year":"2020","journal-title":"J Environ Health Sci"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.038_bib0065","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/heapro\/day062","article-title":"Does health literacy mediate the relationship between socioeconomic status and health disparities? Integrative review","volume":"34","author":"Stormacq","year":"2019","journal-title":"Health Promot Int"},{"key":"10.1016\/j.jtct.2026.04.038_bib0066","article-title":"Information needs for treatment decision-making of hematopoietic cell transplant patients 65 years or older and caregivers","author":"Foster","year":"2019","journal-title":"J Cancer Educ"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.038_bib0067","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1188\/16.CJON.433-436","article-title":"Applying health literacy principles: strategies and tools to develop easy-to-read patient education resources","volume":"20","author":"Foster","year":"2016","journal-title":"Clin J Oncol Nurs"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.038_bib0068","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3324\/haematol.2012.066100","article-title":"Survival for older patients with acute myeloid leukemia: a population-based study","volume":"97","author":"Oran","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.038_bib0069","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/1055-9965.EPI-14-0963","article-title":"How Do Differences in Treatment Impact Racial and Ethnic Disparities in Acute Myeloid Leukemia?","volume":"24","author":"Patel","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.038_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2015.188","article-title":"Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989\u20132012","volume":"30","author":"Dinmohamed","year":"2016","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.jtct.2026.04.038_bib0071","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/bloodadvances.2018019125","article-title":"Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States","volume":"2","author":"Bhatt","year":"2018","journal-title":"Blood Adv"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:41:56Z","timestamp":1793392916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726003271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":70,"alternative-id":["S2666636726003271"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.038","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Associated with Receipt of Allogeneic Hematopoietic Cell Transplant and NMDP Donor Search in Older Adults with Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}